**Background**
The regulation of the autonomic nervous system is critical for maintaining homeostasis, particularly in the control of vascular tone and organ function. The sympathetic nervous system utilizes vasoconstrictor neurotransmitters to modulate blood flow and gastric motility. Dysregulation of these adrenergic pathways can lead to various physiological imbalances, making the inhibition of presynaptic neurotransmitter release a key area of pharmacological research. Understanding how to selectively block adrenergic ganglia and sympathetic nerves allows researchers to investigate the specific contributions of noradrenergic nerves to cutaneous vasodilator responses and gastrointestinal functions. In this context, we will introduce a sympathetic nerve blocking agent – Bretylium.
**Definition**
Bretylium (tosylate) is an inhibitor of the presynaptic release of vasoconstrictor neurotransmitters that acts as a sympathetic nerve and adrenergic ganglion blocking agent. According to the Bretylium description, it specifically inhibits adrenergic function presynaptically only after an initial release of neurotransmitter substance.
**In Vitro and In Vivo Studies**
Bretylium is characterized by the Bretylium Formula C18H24BrNO3S and has a molecular weight of 414.36. In terms of Bretylium biological activity, the compound is utilized to attenuate the influence of sympathetic nerves in various physiological models. For researchers seeking a standard Bretylium protocol, the reference for administration dose is 15 mg/kg via intraperitoneal (I.P.) injection. Bretylium In Vivo studies have demonstrated its utility in examining cutaneous blood flow and gastric emptying. For instance, it has been used to evaluate the contribution of noradrenergic sympathetic nerves to the rapid cutaneous vasodilator response to local heating and to investigate the role of vagal afferent fibers in leptin-induced inhibition of gastric emptying in rats. In conclusion, Bretylium is a potent adrenergic ganglion blocking agent effective for studying presynaptic neurotransmitter release.
Keywords
Bretylium, 61-75-6, Adrenergic Receptor, Beta Receptor, Inhibitor, inhibitor, inhibit
References
[1] McGinn R et al. Adenosine receptor inhibition attenuates the suppression of postexercise cutaneous blood flow. J Physiol. 2014 Jun 15;592(12):2667-78.
[2] Tew GA et al. Aging and aerobic fitness affect the contribution of noradrenergic sympathetic nerves to the rapid cutaneous vasodilator response to local heating.
J Appl Physiol (1985). 2011 May;110(5):1264-70
[3] Cakir B et al.Leptin inhibits gastric emptying in rats: role of CCK receptors and vagal afferent fibers. Physiol Res. 2007;56(3):315-22. Epub 2006 Jun 22.